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Available online 20 November 2010Abstract There are two critical stages in the retroviral reprogramming of somatic cells to produce human induced
pluripotent stem cell (hiPSC) lines. One is the production of high titer virus required to reprogram somatic cells; the other
is identification of true hiPSC colonies from heterogeneous cell populations, and their isolation and expansion to generate a
sustainable, pluripotent stem cell line. Here we describe simple, time-saving methods to address the current difficulties at
these two critical junctures. First, we have developed a method to increase the number of infectious viral units 600-fold.
Second, we have developed a TRA-1-81-based positive selection column method for isolating “true” hiPSCs from the
heterogeneous cell populations, which overcomes the labor-intensive and highly subjective method of manual selection of
hiPSC colonies. We have used these techniques to produce 8 hiPSC lines from human fibroblasts and we believe that they are of
considerable utility to researchers in the hiPSC field.
© 2010 Elsevier B.V. All rights reserved.Introduction
Human induced pluripotent stem cell (hiPSC) lines can be
maintained in their undifferentiated state and yet be
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doi:10.1016/j.scr.2010.10.002of considerable promise for the future of in vitro disease
modeling and drug discovery. For example, disease-specific
hiPSC lines from patients with spinal muscular atrophy (Ebert
et al., 2009), familial dysautonomia (Lee et al., 2009), and
amyotrophic lateral sclerosis (Dimos et al., 2008), all
demonstrated disease phenotype in differentiated neurons.
In addition, hiPSC-derived hepatocytes (Sullivan et al., 2010;
Guguen-Guillouzo et al., 2010) and cardiomyocytes (Yokoo
et al., 2009; Tanaka et al., 2009; Zwi et al., 2009) have
applications for drug safety evaluation, bridging the gap.
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human clinical trials. Furthermore, hiPSC lines derived from
patients carrying specific genetic diseases provide a novel
and exciting platform to study drug/disease interactions, an
approach that has not been previously possible.
Takahashi and Yamanaka (2006) first reported the
establishment of murine iPSCs in 2006, by transducing
mouse embryonic fibroblasts with retroviruses encoding c-
Myc, Oct3/4, Sox2, and Klf4. Subsequently, the first hiPSC
lines were derived in 2007 (Yu et al., 2007; Takahashi et al.,
2007), again by employing retroviral transduction of fibro-
blasts. Since this pioneering research, the field of iPSC
research continues to expand rapidly and several attempts
have been made to develop methods that minimise the
random integration of transgenes into the genome, which is
considered necessary for clinical applications. These include
excisable viral cassettes (Kaji et al., 2009; Woltjen et al.,
2009), and nonintegrating adenoviral vectors (Zhou and
Freed, 2009; Stadtfeld et al., 2008), together with nonviral
methods such as repeated plasmid transfection (Okita et al.,
2008) and protein transductions (Kim et al., 2009; Zhou et
al., 2009). However, to date, these methods are associated
with reprogramming efficiencies of as low as 0.0001–0.001%,
which is between 1000-fold and 100-fold lower than
retroviral transduction. Moreover, they are often restricted
to embryonic or fetal tissue, or to mouse cells, whereas the
desired target for clinical relevance would be cells isolated
from adult humans. Therefore, for in vitro biomedical
applications, such as disease modeling or drug screening
where random viral integrations are of lesser significance,
retroviral transduction is still the method of choice.
Although the use of retroviruses in hiPSC production is
now well established, the method is constrained by the
ability to cost-effectively produce lentivirus on a scale large
enough to meet the requirements of the experiment.
Furthermore, the common method for concentrating the
virus by ultracentrifugation requires specialist equipment,
and can be prohibitive due to this cost. Here we demonstrate
that viral yields can be increased 100-fold by optimising the
production conditions, and in addition, the transduction
efficiency can be improved a further 6-fold by conjugating
the virus produced to streptavidin superparamagnetic
particles. This means that a single well within a 6-well
plate can produce between 0.5×107 and 1×107 infectious
units, enough for 10–20 hiPSC experiments in which 50 000
somatic cells are transduced with a multiplicity of infection
of 10. As a result, the labor and cost burden of this element
of hiPSC line production are greatly reduced.
An additional obstacle we have addressed in the produc-
tion of sustainable hiPSC lines is the identification and
subsequent isolation of truly reprogrammed hiPSCs from a
heterogeneous derivation culture that also contains mouse
embryonic fibroblast feeders, somatic cells, and partially
reprogrammed cells of similar morphology to hiPSCs. This
process remains highly subjective, but is critical for the
production of high-quality hiPSC lines. Judgments are made
on the basis of appearance with the “best looking,” and often
faster growing colonies being selected for propagation. In
addition, this process of mechanical dissection and passage
to culture the new hiPSC line is highly labor-intensive.
Therefore, we have developed an isolation method involving
the positive selection of “true” hiPSCs based on the cellsurface expression of the pluripotency marker TRA-1-81,
previously shown to be the most appropriate marker for
identification of fully reprogrammed hiPSCs in culture (Chan
et al., 2009). Not only does this eliminate the selection bias,
but because manual identification and mechanical dissection
are replaced with bulk trypsin passaging, the process is
simplified and allows many lines to be derived at once.
In summary, the twomethodswe describe here are not only
both time and cost-saving but they require no specialised
equipment, they minimise technical skill, and, most impor-
tantly, they accelerate establishment of hiPSC lines.
Results and discussion
Optimisation of lentivirus production increases
transduction efficiency by 600-fold
To optimise lentiviral production, we evaluated the influ-
ence of several parameters including density of packaging
cells, transfection method, and DNA concentration. We also
investigated harvesting times and frequencies, the influence
of serum, and concentration methods to increase eventual
viral titer. Finally, we investigated conjugation of virus to
streptavidin superparamagnetic particles to determine the
effect on transduction efficiency. Optimisation experiments
were performed using a lentivirus encoding eGFP and titers
were quantified by transducing both the fibroblasts and the
hESC line, HUES7, with serial dilutions of GFP lentivirus,
analysing by flow cytometry, and calculating the infection
units within the linear range of the graph. The results are
detailed in Fig. 1 and Supplementary Fig. 1.
Since previous reports utilise different cell numbers and
DNA concentrations for viral production, we first evaluated
the effect of these two factors on titer. This indicated that
an increase in packaging cell number was proportional to the
amount of virus produced. Moreover, the amount of total
plasmid DNA used to make the virus was inversely propor-
tional to the viral yield (Supplementary Fig. 1a). Under these
conditions, transfection using Lipofectamine 2000 yielded
more than twice the number of infectious units per milliliter
(iu/ml) than calcium phosphate precipitation transfection
methods (Supplementary Fig. 1b).
Next the timing and frequency of viral harvest were
investigated. In most reports, transfection reagents are
removed from the packaging cells 24 h post transfection and
supernatant containing virus is collected once at 48–72 h
post transfection. In our hands, this strategy led to a viral
titer of ~2.5×104 iu/dish. However, by changing to a shorter
incubation of 4–5 h for the transfection, and coupling this to
multiple viral harvests at 20, 30, and 48 h, the pooled viral
titer was increased over 10-fold to ~3.5×105 iu/dish, and
when Lipofectamine 2000 was used this was further
increased to ~1×106 iu/dish (Supplementary Fig. 1c). This
could be due to several factors. The most likely explanation
is that the half-life of lentivirus at 37 °C is around 17 h
(Chilton and Le Doux, 2008), and therefore the number of
infectious units of virus in the culture supernatant reaches an
equilibrium, rather than continually increasing. Thus our
procedure of harvesting at regular intervals and immediately
storing the virus at -80 °C preserves the yield. In addition,
the fresh nutrients provided by repeated medium changes
Figure 1 Optimisation of lentivirus production with a GFP-encoding lentivirus. (a) Schematic of lentivirus production in a single 6-well
plate. BL15 cells were transfected with plasmids encoding OCT4, SOX2, LIN28, and NANOG together with the relevant packaging and
envelope plasmids following preconditioning of the BL15 cells with biotin. Viral supernatants were harvested at 20, 30, and 48 h post
transfection, pooled, and filtered, and the pH was adjusted to 7.7. Calcium chloride was then added to a final concentration of 60 mM to
induce precipitation. The viral particles precipitate out of solution with the calcium phosphate,which is then collected by centrifugation.
The viral particles, once resuspended, are then conjugated to streptavidin beads. (b) Infection of fibroblasts (i–iv, vii) and HUES7 (v, vi,
viii) with a GFP-encoding lentivirus. Fibroblasts were transduced at an MOI of 10 and are shown pretransduction (i), 24 h posttransduction
showing beads stuck to cells (ii), 96 h posttransduction the fibroblasts become confluent (iii) and express GFPwith high efficiency (iv, vii).
HUES7 cells were transduced at an MOI of 25 and also express GFPwith high efficiency (v, vi, viii). Scale bars represent 100 μm. Using flow
cytometry, transduction efficiency could be quantified to almostN99% in both cell types (vii, viii). (c) An experiment to optimise lentivirus
production. Graph shows calcium phosphate precipitation transfection with single collection (single) or multiple harvest (multiple) and
Lipofectamine 2000 transfection with multiple harvest (lipo multiple) both before and after bead conjugation.
160 E. Dick et al.likely enhance the viability of packaging cells. Furthermore,
the inclusion of additional sodium pyruvate, as an energy
source, in the culture medium during viral production
maximises the packaging efficiency of the producer line,
increasing the virus-making ability.
The method of viral concentration can have a major
influence on titer. Here we used coprecipitation with calcium
phosphate, coupled with virus conjugation to streptavidin
superparamagnetic particles (Chan et al., 2005; Pham et al.,
2001). In contrast to ultracentrifugation, which requires
specialist equipment, and can damage viral vectors and
reduce viral viability (Kamps et al., 1991), or spin concentra-
tion columns that are costly, this method is straightforward,consistent, and inexpensive. In order to induce precipitation
from the phosphate-rich medium with calcium chloride, the
viral supernatant must be serum free (Pham et al., 2001).
Surprisingly, we found that removing serum from the virus
production medium doubled the eventual viral yield achieved,
even before concentration (Supplementary Fig. 1c). Conjuga-
tion of lentiviral particles to streptavidin superparamagnetic
particles was made possible by employing a modified 293T
packaging cell line, BL15 (Nesbeth et al., 2006), which express
a biotin binding protein on their surface. When BL15 cells are
preconditioned with biotin theymetabolically couple biotin to
a membrane-anchored biotin acceptor peptide (BAP). In the
final assembly of a lentiviral particle, the virus is released from
161New protocols to enhance the production and isolation of human induced pluripotent stem cell linesthe packaging cell and incorporates both viral and nonviral
membrane-associated proteins. As a result of being produced
in the BL15 cells, the surface of the virus particle is coatedwith
a specific subset of proteins modified with biotin. The
lentiviral particles can then be effectively bound to strepta-
vidin superparamagnetic particles (Nesbeth et al., 2006)
(schematic in Fig. 1a). In addition to the advantage of
concentrating the viral supernatant into small volumes, the
streptavidin superparamagnetic particles also enhance the
transduction efficiency approximately 6-fold (6.37±0.17
[SEM]) (Fig. 1c), presumably by enhancing viral docking by
bringing the cells in contact with the beads (Fig. 1b, ii). The
beads did not appear to be toxic, although some persist in
culture for several weeks; often reprogrammed colonies could
be seen with beads attached round the edges. The lentivirus
produced could be used to transduce both fibroblasts and
HUES7 cells at N99% efficiency when used at a multiplicity of
infection of 10 or 25, respectively (Fig. 1b). Furthermore, due
to the optimisation steps, lentivirus production can be
performed on a much smaller scale than previously documen-
ted (Park et al., 2008a). The flow cytometry method used to
titer the virus allows calculation of the number of infectious
virus particles in a given volume. As the virus was titered in the
fibroblast target cell population, we were able to determine
the amount of virus required for reprogramming experiments.
Our preferred procedure is summarised in Fig. 1a and under
Materials and methods. As a result, a single well of a 6-well
plate, for each of the four iPSC factors, produced enough
lentiviral particles for between 10 and 20 iPSC reprogramming
experiments. This drastically reduces the burden of lentivirus
generation, limiting the production phase of the experiment
from as many as 6×10 cm plates per virus (i.e., a growth area
of 360 cm2) (Park et al., 2008a) down to a singlewell of a 6-well
plate (i.e., 10 cm2).Isolation of hiPSCs from culture and derivation of
stable lines
Following transduction with OCT4, SOX2, NANOG, and LIN28,
cells were transferred to mitotically inactivated mouse embry-
onic fibroblast (MEF) feeder layers and cultured for 25–30 days
with daily medium changes. Partially reprogrammed granular
colonies were observed from Days 8–9 onward and small hiPSC
colonies emerged from Day 11. After 20–30 days of somatic cell
reprogramming, cultures typically comprised MEFs, supporting
the proliferation of nonreprogrammed somatic cells, partially
reprogrammed granular colonies, and a minority of fully
reprogrammed hiPSC colonies. At this stage, identified hiPSC
colonies could bemechanically dissected from derivation plates
and transferred to fresh MEFs. However, this method is labor-
intensive, time consuming, and highly subjective, with only the
“best” colonies being selected for propagation. Moreover, this
technique represents a major bottleneck in the derivation of
new hiPSC lines. To overcome these issues, we developed a
rapid, simple, and time-saving method for isolating true hiPSC
from the heterogeneous cell populations that eliminates bias
and which can be utilised immediately after somatic cell
reprogramming (schematic Fig. 2a).
On Days 25–30, live cultures were stained with a
phycoerthrin (PE)-TRA-1-81 antibody to identify true hiPSC
colonies (Chan et al., 2009) (Fig. 2b). In some cultures,colonies were marked for mechanical dissection with a stem
cell knife, and transferred to fresh mitotically inactive MEF
feeders. Other cultures were harvested by trypsin/EDTA,
stained with a PE-TRA-1-81 antibody, and then incubated with
a secondary antibody conjugated to magnetic MicroBeads
(Miltenyi Biotec). The cells were then run over a magnetic
column, which retained the positively labeled cells, whereas
unstained contaminating cells were washed through and
discarded. The positively labeled cells could then be eluted
from the column and be seeded directly onto Matrigel under
feeder-free conditions (Fig. 2a). This has the advantage that
cultures can be cryopreserved at high (~85%) viability using
standard techniques rather than labor-intensive vitrification
methods and can be expanded rapidly, compared to the
mechanical dissection plates. The column enriched the cells to
N95% TRA-1-81 positivity (Fig. 2c, iii). In fact, the method can
also be used to enrich a cell population and isolate the cells
expressing a specific marker at high levels only, by reduced
incubation with the primary antibody (Fig. 2c, ii). In this
regard, hiPSC line cultures were subjected to a second column
after 2–3 passages to ensure almost complete removal of
contaminating non-hiPSC (Fig. 2d). Overall, this method could
be completed in 1 h and, due to its simplicity, many lines can
be processed at once. Following harvest of cells from the
magnetic column, and seeding to a T25 flask under feeder-free
conditions onMatrigel, itwas possible to yield a confluent flask
(~3×106 hiPSCs) within a week. This meant that these cells
could be cryopreserved on mass using DMSO as the protectant
in just over a week after columnisation. In contrast, expanding
hiPSC colonies by mechanical passage to produce this number
of cells took several weeks and typically required 5–10
passages within multiple dishes. To bank these cells at early
passage, the labor-intensive and highly technical vitrification
method was used as it is better suited to freezing colonies
(Reubinoff et al., 2001). Overall, the advantage of processing
multiple lines simultaneously, and the ability to generate high
numbers of cells relatively quickly, improves on the labor
intensity of mechanical passage. A summary of our preferred
methodology is described in Fig. 2a and under Materials and
methods. It is important to note that with this method
individual clones are not maintained independently, and are
instead pooled to produce a polyclonal population. This
method may have the drawback that individual clones cannot
therefore be analysed for specific aspects, such as number of
transgene integrations. However, it is well established in
somatic and stem cells that as each clone expands, each of the
daughter cells within the clone will acquire its own phenotype
due to stochastic changes in, for example, epigenetic status
(Baup et al., 2010) and proliferation rate (Smith and Whitney,
1980). Therefore, it is a slight misconception to assume that
clonally derived cells are always best. Our polyclonal system
has the advantages of accelerating the derivation process,
averaging all clones, and making the workload of maintaining
multiple patient samples more manageable. Nevertheless, if
single clones are required, they can be derived by low density
seeding at a later time.Characterisation of hiPSC lines
The pluripotency of hiPSC lines produced by the positive
selection method was assessed using accepted techniques (Yu
162 E. Dick et al.et al., 2007; Chan et al., 2009; Park et al., 2008b). Cell lines
were grown to passage 15 under feeder-free conditions on
Matrigel and analysed at p15–25 to normalise against a control
hESC line, HUES7, which were typically used at p17–30. Cells
were analysed for the expression of pluripotency markers by
immunofluorescence and flow cytometry (Figs. 3a and b;
Supplementary Fig. 2). All lines showed expression of proteins
associated with pluripotency, including OCT4, SOX2, LIN28,
NANOG, TRA-1-81, SSEA4, KLF4, DNMT3B, REX1, cMYC, and
were negative for the differentiation marker SSEA1 and the
fibroblast marker P4HB. Metaphase spreads at passages 15 and25 confirmed that the cells showed normal karyotype
(representative karyogram of 30 spreads/line/passage num-
ber, Fig. 3c). Cells were grown over several passages to
determine their population doubling rate (Fig. 3d), and were
found to have different growth rates, but all within the
published range for hESCs (Cowan et al., 2004; Xu et al., 2001).
To determine whether the hiPSC lines were pluripotent, cells
were analysed to determine whether they had the ability to
differentiate into three germ layers in vitro and form
termatomas in vivo. In the in vitro assay, hiPSC were
differentiated into embryoid bodies (EBs), as previously
163New protocols to enhance the production and isolation of human induced pluripotent stem cell linesdescribed (Burridge et al., 2007), and fixed at 30 days in 4%
paraformaldehyde. These EBs showed formation of ectoderm
shown by the expression of β-III-tubulin, endoderm shown by
α-fetoprotein, and mesoderm by the formation of beating
clusters staining positive for α-actinin (Fig. 3e). In the in vivo
assay, hiPSC were injected into the kidney capsule of NOD/
SCID mice (Priddle et al., 2009). Teratomas were collected at
Days 50–60, fixed, and embedded in paraffin wax. Sections
were stained with hematoxylin and eosin and confirmed to
express the three germ layers represented by early neuroec-
toderm, primitive gut endothelium (endoderm) andpremature
cartilage (mesoderm) (Fig. 3e). The methylation status of the
OCT4 and NANOG promoters was determined in primary
fibroblasts, reprogrammed hiPSCs, and their differentiated
progeny, using the HUES7 hESC line as a control, and were
found tobeunmethylated or hypomethylated inHUES7 and the
hiPSC lines, while they were hypermethylated in primary
fibroblasts and differentiated hiPSC progeny (Fig. 3g).
In conclusion, here we outline two key methods for the
efficient and simplified production of hiPSC lines. The lines
produced by this method are karyotypically stable and fulfill
the accepted criteria to class them as true hiPSC10, 29. In
addition, the methods described here are relevant to many
other applications. For example lentivirus is widely used as a
genetic modification technique, so simplified, high titer
virus production is an invaluable technique. Furthermore,
the positive selection method described here is generically
applicable and can be adapted to purify any cell type based
on surface marker expression. This includes enriching hESCs
from cultures that contain differentiated cells and selection
of specific cell lineages following differentiation.
Materials and methods
Optimised protocol for production of VSV-G enveloped
lentivirus particles
Lentiviral expression plasmids encoding OCT4, SOX2, LIN28,
and NANOG were sourced from Addgene (Yu et al., 2007).
Lentiviral particles were produced using a 293T cell line,
BL15, modified to express a biotin acceptor peptide domain
on its cell surface (Chan et al., 2005; Nesbeth et al., 2006).
BL15 cells were maintained in DMEM with 10% FCS. BL15 cells
were pretreated with 100 μM A-biotin (Sigma) for 3 days,Figure 2 Isolation of hiPSCs by positive selection. (a) A schematic
trypsinised from the derivation plate, filtered, and incubated with TRA
conjugated to magnetic MicroBeads. Labeled cells were run through a m
column. Finally the cells were expelled from the column and returned to
hiPSC derivation; (i) granular type 1 colony on Day 11, (ii) small hiPSC col
live staining with a TRA-1-81-PE antibody at Day 25, under DIC microsco
flow cytometry histograms indicating column enrichment. Filled histogr
green postcolumn analysis. By way of control (i) shows HUES7 expressin
enrichment postcolumn of the cells expressing TRA-1-81 at a higher leve
enrichment of the TRA-1-81-positive cells. (d) Representative images of
conditions (i–iv) and cells transferred under feeder-free conditions from
morphology; however colonies began to emerge after a few days, seen in
(iii). Cells were often recolumnised after 2–3 passages afterwhich a homo
In manual passage culture, hiPSC colonies on MEFs were passaged to p7
settle under feeder-free conditions. Representative images showcells at
(p11: p7 on MEFs + p5 on Matrigel) (viii). Scale bars represent 100 μm.prior to viral production. On the day before transfection,
BL15 cells were seeded at a density of 1×106 cells/well in
gelatin-coated 6 well plates, in medium containing 100 μM
biotin. One hour prior to transfection, medium was changed
to Opti-MEM (Invitrogen) with 10% FCS supplemented with
100 μM biotin. Transfection mixes were set up as follows for
each virus, for one well of a 6-well plate; mix A, 150 μl Opti-
MEM plus 15 μl of Lipofectamine 2000 (Invitrogen); and mix
B, 150 μl Opti-MEM and 0.5 μg pMD2.G (Addgene), 1.25 μg
psPAX2 (Addgene), and 1.67 μg of the appropriate iPS factor
expression plasmid. These were incubated separately for
5 min and then together for 20 min before adding to the
relevant well of the 6-well plate. Transfection mixes were
removed from the cells after 5 h and medium was replaced,
after washing, with DMEM (serum-free) supplemented with
1 mM sodium pyruvate (Invitrogen). Viral supernatant was
harvested at 20, 30, and 48 h post transfection, each time
replacing the medium with DMEM supplemented with sodium
pryuvate. Each collection was stored at -80 °C until use.
After the final viral collection, harvests were thawed,
pooled, and filtered, and the pH was adjusted to 7.7. To
precipitate the virus particles, 1 M CaCl2 was added to a final
concentration of 60 mM. The viral supernatant was incubat-
ed at 37 °C for 30–40 min to form a calcium phosphate (Ca3
(PO4)2) precipitate, and then centrifuged at 4000 g for 5 min.
The Ca3(PO4)2/virus pellet was resuspended in 1–2 ml EDTA
buffer (100 mM EDTA in 50 mM NaCl, pH 6.5). This virus could
then be snap-frozen in aliquots at and stored at -80 °C with
no significant loss of activity (Supplementary Fig. 1d). To
facilitate the removal of the EDTA buffer and to enhance
transduction efficiency virus was conjugated to streptavidin
paramagnetic beads (Promega), using 600 μl of beads for the
four pooled iPS viruses. Virus was conjugated to beads for 3–
5 h at room temperature on a roller. Following this
incubation, the supernatant was removed and the remaining
beads were resuspended in DMEM with 10% FCS. Each well of
a 6-well plate made approximately 0.5–1×107 infectious
virus particles. Enough to transduce 10–20 plates of
fibroblasts at an MOI of 10.Culture and transduction of human dermal fibroblasts
Human dermal fibroblasts from patients with muscular
dystrophy (DMD11, DMD15, DMD16, and DMD19) and Longof positive selection of hiPSC over a magnetic column. Cells were
-1-81-PE antibody, followed by incubation with secondary antibody
agnetic column where positively labeled cells were retained on the
culture under feeder-free conditions. (b) Representative images of
ony with evidence of beads round the edge on Day 15, and (iii–vi) of
pe (iii, v) and a fluorescence microscope (iv, vi). (c) Representative
ams show the isotype control with red lines showing precolumn and
g TRA-1-81, and (ii) shows HUES-hiPSC line expressing TRA-1-81 and
l. In (iii) a patient hiPSC line is shown pre- and postcolumn showing
cells, postcolumn enrichment and after transfer under feeder-free
MEFs (v–viii). First 24 h postcolumn (i) cells often did not show hESC
(ii). These cells grew to represent a large proportion of the culture
geneous populationwas observed under feeder-free conditions (iv).
(v) before transfer onto Matrigel (vi). Cells took several passages to
p2 onMatrigel (p9: p7 onMEFs + p2Matrigel) (vii), and p5 onMatrigel
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punch biopsies, after informed consent was given by the
patients. The studies are approved by the local ethics
committee. DMD fibroblasts were obtained from the BioBank
of the MRC Centre for Neuromuscular Diseases (Newcastle).
Fibroblasts were grown in DMEM supplemented with 10% FCS,
0.1 mM nonessential amino acids (Invitrogen), and 2 mM L-
glutamine (Invitrogen). An embryonic fibroblast line, derived
from differentiation of the hESC line HUES7, was used as a
control (HUES-Fib) and was cultured in the same medium. On
the day of transduction fibroblasts were seeded into tissue
culture-treated 6-well plates (NUNC) at a density of 50 000
cells/well and left to settle for 5–6 h. Once the cells had
adhered to the plastic they were infected with the virus/
bead mix at an MOI of 10, in the presence of 8 μg/ml
Polybrene (Sigma-Aldrich). Medium was changed after 24 h
with normal growth medium. After a further 24 h, cells were
typsinised and resuspended in hiPSC culture medium (DMEM-
F12 supplemented with 15% KSR, 100 μM β-mercaptoetha-
nol, 10 ng/ml bFGF (Sigma-Aldrich), 4.5 mM GlutaMAX-1
(Invitrogen), and 0.1 mM nonessential amino acids). Cells
were transferred to 90-mm dishes containing mitomycin
C-inactivated MEFs at a density of 1.8×106 cells/plate. The
medium was changed daily: for the first week with hiPSC
culture medium, and then for the rest of the experiment,
with MEF-conditioned medium (prepared as previously
described (Braam et al., 2008)), supplemented with
10 ng/ml bFGF.
Live staining of hiPSC colonies
To mark true hiPSC colonies for manual dissection, culture
plates were incubated with a phycoerythrin (PE)-conjugated
TRA-1-81 antibody (BD) at a 1 in 200 dilution in culture
medium for 15 min. Cells were then washed and then imaged
under an inverted fluorescence microscope (Nikon Eclipse TE
2000).
Positive selection of true hiPSC
For derivation of hiPSC lines, colonies were either cut from
the derivation plate and cultured on MEFs (as previously
described Burridge et al., 2007) or trypsinised from the plate
and isolated by positive selection over a magnetic column.
For the positive selection method, the derivation plate was
treated with 0.05% trypsin/EDTA to loosen the MEF layer,
and the culture was transferred to a 50-ml tube as one sheet
in approximately 20 ml culture medium. Using a 10-mlFigure 3 Characterisation of hiPSC lines. (a) Expression of plu
immunofluorescence; for a more extensive list see Supplementary Fi
the surface marker expression of TRA-1-81 and SSEA4, with no e
histogram). (c) A representative karyogram of hiPSC lines; all of wh
growth kinetics of the hiPSC lines all falling within the normal range
were differentiated in vitro to form EBs, and fixed at Day 30. The e
expression of ectoderm, endoderm, and mesoderm, respectively. In
three germ layers with representative images shown in (f). Furthe
pictures, can be found in Supplementary Fig. 3. Finally, methylatio
several of the hiPSC lines, which showed the same pattern as the
determination of methylation status can be found in Supplementarypipette, cells were forcibly pipetted up and down to recover
the hiPSCs and other cells attached to the MEF layer. The
resultant cell suspension was then filtered through a 40-μm
cell strainer (BD) to remove the large MEF “clumps.” The
supernatant was spun at 300 g for 5 min and then washed in
ice-cold column buffer (Hanks balanced salt solution, HBSS,
with 2% FCS, pH 7.4). After the wash, the cell pellet was
resuspended in 200 μl ice-cold column buffer containing 1 in
200 dilution TRA-1-81 PE-conjugated antibody, and incubat-
ed in the dark at 4 °C for 15 min. After the incubation, 5 ml
of ice-cold column buffer was added to wash the cells and
the solution was spun at 300 g for 5 min. The cell pellet was
resuspended in 80 μl ice-cold column buffer plus 20 μl PE-
MicroBeads (Miltenyi Biotec) and incubated for 15 min in the
dark at 4 °C. After the incubation, 5 ml of ice-cold column
buffer was added to wash the cells and the solution was spun
at 300 g for 5 min. During the spin, a MS column (Miltenyi
Biotec) was placed in its magnet attached to a magnet stand
(Miltenyi Biotec) and primed with 500 μl ice-cold column
buffer. The cell pellet was resuspended in 500 μl ice-cold
column buffer and transferred to the column. The cell
suspension was allowed to drip through the column, by
gravity flow, with a tube catching the negative, flowthrough,
population. The column was washed three times with column
buffer and then the column was removed from the magnet
and transferred to a fresh tube. Cells were ejected by
applying 1 ml of column buffer to the column and then
inserting the supplied plunger. Cells were spun at 300 g for
2 min, resuspended in MEF-conditioned medium, and then
transferred under feeder-free conditions on Matrigel-coated
dishes or flasks, as described previously (Denning et al.,
2006).Growth and maintenance of hESC and hiPSC
The HUES7 cell line and derived hiPSC lines were maintained
on Matrigel as previously described (Denning et al., 2006).Detection of pluripotency marker expression
For flow cytometry analysis, cells were harvested and fixed
in 4% paraformaldehyde (PFA, Sigma-Aldrich), and then
resuspended in PBS with 2% FCS. Cells were incubated with
fluorescently conjugated antibodies, or relevant isotype
controls, for 20 min in the dark at room temperature,
washed, and run through the flow cytometer (FC500, BD
Biosciences).ripotency markers OCT4 and LIN28 in the 6 hiPSC lines by
g. 2. (b) Flow cytometry histograms of the hiPSC lines indicating
xpression of SSEA1 which overlays the isotype control (filled
ich showed a normal karyotype both at p15 and at p25. (d) The
of population doublings under feeder-free conditions. In (e) cells
xpression of β-III-tubulin, α-fetoprotein, and α-actinin indicates
vivo differentiation assays also indicated the expression of the
r information regarding teratomas, including larger annotated
n status of the OCT4 and NANOG promoters was investigated in
HUES7 control hESC line (g). Further information regarding the
Fig. 4. Scale bars represent 130 μm.
166 E. Dick et al.For immunocytochemistry, cells were grown to conflu-
ence in chamber slides (NUNC) and then fixed in 4% PFA. Cells
were permeabilised with 0.1% Triton X-100 (Sigma-Aldrich),
and blocked with 8% goat or rabbit serum (Sigma-Aldrich) in
PBS, as appropriate. Primary antibody incubations were
performed overnight at 4 °C and secondary antibodies at
room temperature for 1 h. Cells were imaged using a Nikon
Eclipse 90i fluorescence microscope.
Determination of karyotype stability
Metaphase spreads for karyotype analysis were prepared as
previously described (Braam et al., 2008). Cell karyotype was
assessed at passage 15 after derivation and then again at
passage 25 to determine stability.
Differentiation into three germ layers in vitro
The hiPSC lines were tested to determine whether they could
form three germ layers in vitro following embryoid body
formation as previously described (Burridge et al., 2007). EBs
were fixed at Day 30 and analysed for the expression of
proteins representing the three germ layers: β-III-tubulin for
ectoderm, α-fetoprotein for endoderm, and α-actinin for
mesoderm. Expression of these proteins was analysed by
immunocytochemistry as described above.
Teratoma formation in NOD/SCID mice
The hiPSC lines were tested to determine whether they could
form teratomas and consisting of the three germ layers in
vivo. Teratomas were formed by injection of hiPSCs into the
kidney capsule of NOD/SCID mice as previously described
(Priddle et al., 2009). Tumors were collected between 50
and 60 days post injection and fixed in 4% PFA, embedded in
paraffin wax, sectioned, and stained with hematoxylin and
eosin as previously described (Priddle et al., 2009). The germ
layers were identified under a light microscope.
Bisulfite sequencing of genomic DNA
Cell pellets from fibroblasts, reprogrammed hiPSC lines, and
their differentiated progeny were analysed to determine the
methylation status of the endogenous OCT4 and NANOG
promoters. Genomic DNA was extracted from frozen cell
pellets of fibroblasts, reprogrammed iPSC lines, and their
differentiated progeny (Qiagen DNeasy Blood and Tissue kit).
Genomic DNA (1 μg) was digested overnight at 37 °C with
PacI enzyme (1 μl of 10 U/μl; NEB), and subsequently
bisulfite-treated as described previously (Kim et al., 2007).
Bisulfite PCR primers (Invitrogen) were designed using
MethPrimer software for NANOG (F, TGGTTAGGTTGGTTT-
TAAATTTTTG; and R, AACCCACCCTTATAAATTCTCAATTA) or
were previously published for OCT4 (Deb-Rinker et al.,
2005). Bisulfite PCR was performed in a final volume of 25 μl,
comprising Platinum Taq (0.125 μl Invitrogen), 5 μM forward
and reverse primers (6 μL; Invitrogen), 10X Reaction buffer
(2.5 μl; Invitrogen), 2.5 mM dNTPs (1.25 μl; Invitrogen),
1.5 mM MgCl2 (0.75 μl; Invitrogen), and 1 μl of bisulfite
converted DNA. The PCR cycling conditions were 95 °C for10 min followed by 40 cycles (95 °C for 1 min, 63 °C for
1 min, 72 °C for 1 min) and a final extension step at 72 °C for
10 min. PCR products were purified (QIAquick gel extraction
kit; Qiagen) and direct sequencing was performed to assess
DNA methylation, using the forward primer for each gene.
Results were represented using a five-category classifica-
tion, as described in Supplementary Fig. 4.
Distinguishing between endogenous and lentiviral
expression of OCT4, SOX2, NANOG, and LIN28
RNA extraction from frozen cell pellets was performed using
the Qiagen RNeasy Mini kit (Qiagen), according to the
manufacturer's instructions. Reverse transcription was per-
formed using the First Strand cDNA Synthesis kit (GE
Healthcare), with 100 ng RNA. RT-PCR was performed in a
total volume of 25 μl, which was composed of Hotstar Taq
polymerase (0.125 μl; Qiagen), 5 μM forward and reverse
primers (2.5 μl; Invitrogen), 10x Reaction buffer (2.5 μl;
Qiagen), 2.5 mM dNTPs (2.5 μl; Invitrogen) and 2 μl of cDNA.
The PCR cycling conditions were 95 °C for 15 min followed by
35 cycles (95 °C for 1 min, 57 °C for 90 s, 72 °C for 1 min) and
a final extension step at 72 °C for 5 min. Primers for RT-PCR
are in Supplementary Table S1.
Statistics
Statistics were performed using Prism Software (Version 5.0
GraphPad, San Diego, CA).
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